Economic evaluation of antibacterials in the treatment of acute sinusitis

PharmacoEconomics

Volumn 15, Issue 1, 1999, Pages 97-113

  Laurier, Claudine ^a   Lachaine, Jean ^a   Ducharme, Murray ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; CEFACLOR; CEFUROXIME; CLARITHROMYCIN;

ADULT; ANTIBACTERIAL ACTIVITY; ARTICLE; DIAGNOSTIC VALUE; DOSE RESPONSE; DRUG COST; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL DECISION MAKING; OUTPATIENT CARE; PATIENT COMPLIANCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; SINUSITIS; SOCIOECONOMICS; TREATMENT OUTCOME;

ACUTE DISEASE; ADULT; ANTI-INFECTIVE AGENTS; HUMANS; SINUSITIS;

EID: 0032907462     PISSN: 11707690     EISSN: None     Source Type: Journal    
DOI: 10.2165/00019053-199915010-00007     Document Type: Article

References (73)

1. 1. Low DE, Desrosiers M, McSherry J, et al. A practical guide for the diagnosis and treatment of acute sinusitis. Can Med Assoc J 1997; 156 (6 Suppl.): S1-14
2. 2. Friedman RA, Harris JP. Sinusitis. Annu Rev Med 1991; 42: 471-89
3. 3. IMS Canada. Canadian Disease and Treatment Index 1996. Plymouth (MA): IMS America, 1996
4. 4. Weinstein L. Diseases of the upper respiratory tract. In: Isslebacher KJ, Adams RD, Brauwald E, et al., editors. Harrison's principles of internal medicine. New York (NY): McGraw-Hill Book Company, 1980
5. 5. Garrelts JC, Herrington AM. Cost effective treatment of lower respiratory tract infections. Pharmacoeconomícs 1996; 10: 36-58
6. 6. Gwaltney JM, Jones JG, Kennedy DM. Medical management of sinusitis: educational goals and management guidelines. Ann Otol Rhinol Laryngol Suppl 1995; 167: 22-30
7. 7. Evans KL. Diagnosis and management of sinusitis. BMJ 1994; 309: 1415-22
8. 8. Dohlman AW, Hemstreet MPB, Odrezin GT, et al. Subacute sinusitis: are antimicrobials necessary? J Allergy Clin Immunol 1993; 91: 1015-23
9. 9. Van Buchem FL, Knottnerus JA, Schrijnemaekers VJJ, et al. Primary-care-based randomized placebo-controlled trial of antibiotic in acute maxillary sinusitis. Lancet 1997; 349: 683-7
10. 10. Kankam GG, Sallis R. Acute sinusitis in adults: difficult to diagnose, essential to treat. Postgrad Med 1997; 102: 253-8
11. 11. Mattucci KF, Levin WJ, Habib MA. Acute bacterial sinusitis. Minocycline vs amoxicillin. Arch Otolaryngol Head Neck Surg 1986; 112 (1): 73-6
12. 12. Scheld WM, Sydnor A, Farr B, et al. Comparison of cyclacillin and amoxicillin for therapy for acute maxillary sinusitis. Antimicrob Agents Chemother 1986; 30: 350-3
13. 13. Nord CE. Efficacy of penicillin treatment in purulent maxillary sinusitis, a European multicenter trial. Infection 1988; 16: 209-14
14. 14. Brodie DP, Knight S, Cunningham K. Comparative study of cefuroxime axetil and amoxicillin in the treatment of acute sinusitis in general practice. J Int Med Res 1989; 17 (6): 547-51
15. 15. Marchi E. Comparative efficacy and tolerability of clarithromycin and amoxycillin in the treatment of out patients with acute maxillary sinusitis. Curr Med Res Opin 1990; 12: 19-24
16. 16. Casiano RR. Azithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Am J Med 1991; 91 Suppl. 3A: 27S-30S
17. 17. Karma P, Pukander J, Penttila M, et al. The comparative efficacy of clarithromycin and amoxycillin in the treatment of outpatients with acute maxillary sinusitis. J Antimicrob Chemother 1991; 27 Suppl. A: 83-90
18. 18. Felstead SJ, Daniel R, European Azithromycin Study Group. Short-course treatment of sinusitis and other upper respiratory tract infections with azithromycin: a comparison with erythromycin and amoxycillin. J Int Med Res 1991; 19: 363-72
19. 19. Nyffenegger R, Riebenfeld D, Macciocchi A. Brodimoprim versus amoxicillin in the treatment of acute sinusitis. Clin Ther 1991; 13 (5): 589-95
20. 20. Edelstein DR, Avner SE, Chow Jm, et al. Once-a day therapy for sinusitis: a comparison of cefixime and amoxicillin. Laryngoscope 1993; 103: 33-41
21. 21. Calhoun KH, Hokanson JA. Multicenter comparison of clarithromycin and amoxicillin in the treatment of acute maxillary sinusitis. Arch Fam Med 1993; 2 (8): 837-40
22. 22. Huck W, Reed BD, Nielsen W, et al. Cefaclor vs amoxicillin in the treatment of acute, recurrent and chronic sinusitis. Arch Fam Med 1993; 2: 497-503
23. 23. Von Sydow C, Savolainen S, Soderqvist A. Treatment of acute maxillary sinusitis: comparing cefpodoxime proxetil with amoxicillin. Scand J Infect Dis 1995; 27 (3): 229-34
24. 24. Hebblethwaite EM, Brown GW, Cox DM. A comparison of the efficacy and safety of cefuroxime axetil and augmentin in the treatment of upper respiratory tract infections. Drugs Exp Clin Res 1987; 13 (2): 91-4
25. 25. Le Clech G, Bourdiniere J. Results of a multicenter study of an amoxicillin-clavulanic acid combination in sinusitis in children and adults. Ann Otolaryngol Chir Cervicofac 1987; 104 (2): 147-50
26. 26. Roge J, Durand B, Pappo M, et al. Treatment of ENT infection with cefuroxime axetil. J Fr Otorhinolaryngol Audiophonol Chir Maxillofac 1989; 38: 138-43
27. 27. Stahl JP, Pappo M. Étude comparative du cefuroxime-axétil versus l'association d'amoxicilline et d'acide clavulanique dans les infections ORL et bronchiques. Sem Hop Paris 1989; 65 (5): 247-51
28. 28. Camacho AE, Cobo R, Otte J, et al. Clinical comparison of cefuroxime axetil and amoxicillin/clavulanate in the treatment of patients with acute bacterial maxillary sinusitis. Am J Med 1992; 93: 271-6
29. 29. Sydnor TA, Scheld WM, Gwaltney J, et al. Loracarbef vs amoxicillin/clavulanate in bacterial maxillary sinusitis. Ear Nose Throat J 1992; 71: 225-32
30. 30. De Abate CA, Perrotta RJ, Dennington ML, et al. The efficacy and safety of once-daily ceftibuten compared with co-amoxiclav in the treatment of acute bacterial sinusitis. J Chemother 1992; 4 (6): 358-63
31. 31. Dubois J, Saint-Pierre C, Tremblay C. Efficacy of clarithromycin vs amoxicillin/clavulanate in the treatment of acute maxillary sinusitis. Ear Nose Throat J 1993; 72 (12): 804-10
32. 32. Gehanno P, Barry B, Chauvin JP, et al. Clarithromycin versus amoxicillin-clavulanate in acute maxillary sinusitis. Pathol Biol 1996; 44 (4): 293-7
33. 33. Nicolletti G, Speciale A, Caccamo F, et al. Sublactam/ampicillin in the treatment of otitis and sinusitis. J Int Med Res 1991; 19 Suppl. 1: 29A-35A
34. 34. Muller O. Comparison of azithromycin versus clarithromycin in the treatment of patients with upper respiratory tract infections. J Antimicrob Chemother 1993; 31 Suppl. E: 137-46
35. 35. Amin NM, Breadon G. An open-label, noncomparative study to evaluate the efficacy, safety, and tolerability of azithromycin in the treatment of patients with acute sinusitis. Clin Ther 1995; 17 (4): 701-7
36. 36. Manzini M, Caroggio A. Efficacy and tolerability of brodimoprim and roxithromycin in acute sinusitis of bacterial origin in adults. J Chemother 1993; 5: 521-5
37. 37. Arndt J, Riebenfeld D, Maier H, et al. Therapeutic efficacy and tolerability of brodimoprim in comparison with doxycycline in acute sinusitis in adults. J Chemother 1994; 6: 322-7
38. 38. Bockmeyer M, Riebenfeld D, Clasen B. Controlled study of brodimoprim and cephalexin in the treatment of patients with acute sinusitis in general practice. Clin Ther 1994; 16: 653-61
39. 39. Freche C, Fombeur JP, Pappo M. Evaluation of cefuroxime-axetil in the treatment of acute sinusitis in adults: comparative study with cefaclor. Thérapie 1988; 43 Suppl. 4: 365-8
40. 40. Gauger U, Inoka P, Germano G, et al. Cefetamet in the treatment of acute sinusitis in adult patients. J Int Med Res 1990; 18(3): 228-34
41. 41. Gehanno P, Depondt J, Barry B, et al. Comparison of cefpodoxime proxetil with cefaclor in the treatment of sinusitis. J Antimicrob Chemother 1990; 26 Suppl E: E87-91
42. 42. Carenfelt C, Mlen I, Odkivst L. Treatment of sinus empyema in adults. Acta Otolaryngol (Stockh) 1990; 110: 128-35
43. 43. Peynegre R, Bossard B, Gehanno P, et al. Efficacité du cefixime dans le traitement des infections otolaryngées de l'adulte. Presse Med 1989; 18: 1608-13
44. 44. Gehanno P, Boucot I, Cicihe D, et al. Traitement ambulatoire des sinusites aigues: évaluation comparative du cefuroxime axetil et du cefixime. Med Maladies Infect 1991; 21: 61-5
45. 45. Matthews BL, Kohut RI, Edelstein DR, et al. Evaluation of cefixime in the treatment of bacterial maxillary sinusitis. South Med J 1993; 86: 329-33
46. 46. Tombolini A, Scheiber E, Pintucci JP, et al. Ceftizoxime in the treatment of bacterial sinusitis-results form a multicentre clinical trial. J Drug Dev 1993; 6 Suppl. 2: 45-8
47. 47. Van Der Wijngaart W, Verbrugh H, Theopold HM, et al. A noncomparative study of cefprozil at two dose levels in the treatment of acute uncomplicated bacterial sinusitis. Clin Ther 1992; 14: 306-13
48. 48. Gehanno P, Berche P, Sinusitis Study Group, et al. Sparfloxacin versus cefuroxime axetil in the treatment of acute purulent sinusitis. J Antimicrob Chemother 1996; 37 Suppl. A: 105-14
49. 49. Dupuis G, Ebbo D, Evennou A, et al. Efficacité et tolérance du cefuroxime-axetil dans les infections des voies aériennes supérieures et de leurs cavités annexes. Rev Laryngol Otol Rhinol (Bord) 1989; 110: 123-6
50. 50. Pessey JJ, Gobert P, Panthier G. Efficacity and safety of cefpodoxime proxetil (cpd) vs cefuroxime axetil (cxm) patient treatment in acute sinusitis. Med Maladies Infect 1994; 24 (6): 686-92
51. 51. Griffiths GK, Vandeenburg MJ, Wight LL, et al. Efficacy abd tolerability if cefuroxime axetil in patients with upper respiratory tract infections. Curr Med Res Opin 1997; 10: 555-61
52. 52. O'Neill SJ, Millar ED, Coles SJ, et al. Safety and efficacy of clarithromycin in the treatment of acute mild to moderate respiratory tract infections. Ir Med J 1991; 84 (1): 33-5
53. 53. DeCampora E, Camaioni A, Leonardi M. Comparative efficacy and safety of roxithromycin and clarithromycin in upper respiratory tract infections. Diagn Microbiol Infect Dis 1992; 15: 119S-22S
54. 54. Boezeman AJ, Kayser AM, Siemelink RJ. Comparison of spiramycine and doxycycline in the empirical treatment of acute sinusitis: preliminary results. J Antimicrob Chemother 1988; 22: 165-70
55. 55. Scandinavian Study group. Loracarbef vs doxycycline in the treatment of acute bacterial maxillary sinusitis. J Antimocrob Chemother 1993; 31: 949-61
56. 56. Husfeldt P, Egede F, Nielsen PB. Antibiotic treatment of sinusitis in general practice: a double blind study comparing ofloxacin and erythromycin. Eur Arch Otorhinolaryngol 1993; 250: S23-5
57. 57. Zeckel MI, Johns D, Masica DN, et al. Twice daily dosing of loracarbef 200mg in the treatment of patients with acute maxillary sinusitis. ClinTher 1995; 17: 215-30
58. 58. Baba S. Clinical efficacy of ofloxacin in the treatment of otothinolaryngological infections. Infection 1986; 14 Suppl. 4: S327-31
59. 59. Fyllingen G, Arnesen AR, Ronnevig J. Phenoxymethylpenicillin two or three times daily in bacterial upper respiratory tract infections: a blinded randomized and controlled clinical study. Scand J Infect Dis 1991; 23: 755-61
60. 60. Williams JW, Holleman DR, Samsa GP. Randomized controlled trial of 3 vs 10 days of trimethoprim sulfamethoxazole for acute maxillary sinusitis. JAMA 1995; 273: 1015-21
61. 61. Sandler NA, Johns FR, Braun TW. Advances in the management of acute and chronic sinusitis. J Oral Maxillofac Surg 1996; 54: 1005-13
62. 62. Harding G. The antibiotic puzzle; guidelines for the family physician. Can J Infect Dis 1997; 8 Suppl. C: 2C-16C
63. 63. Ferguson BJ. Acute and chronic sinusitis. Postgrad Med 1995; 97: 45-57
64. 64. Fairbanks DN. Bacteriology and antibiotics in inflammatory diseases of the sinuses. Otolaryngol Clin North Am 1993; 26: 549-59
65. 65. Scott WG, Tilyard MW, Dovey SM, et al. Roxithromycin versus cefaclor in lower respiratory tracts infections: a general practice pharmacoeconomic study. Pharmacoeconomics 1993; 4: 122-30
66. 66. Scott WG, Cooper BC, Scott HM. Phamacoeconomic evaluation of roxithromycin versus amoxycillin/clavulanic acid in a community-acquired lower respiratory tract infection study. Infection 1995; 23 Suppl. I: S21-4
67. 67. Karalus NC, Garettt JE, Lang DR, et al. A clinical and economic comparison of roxithromycin 150mg twice daily vs amoxicillin 500mg/clavulanic acid 125mg tid for the treatment of lower respiratory tract infections in general practice. Drug Invest 1994; 8: 179-90
68. 68. Carbon C, Hotton JM, Pepin LF, et al. Economic analysis of antibiotic regimens used in the treatment of pharyngitis: a prospective comparison of azithromycin versus roxithromycin. J Antimicrob Chemother 1996: 37 Suppl. C: 151-61
69. 69. Tasch RF, Kunz KC, Marentette MA, et al. A therapeutic and economic evaluation of macrolides antibiotics. Ottawa: Canadian Coordinating Office for Health Technology Assessment (CCOHTA), 1997
70. 70. Alvart R. An open multicentre study to compare the efficacy and safety of sultamicillin with that of cefuroxime axetil in acute ear nose and throat infections in adults. J Int Med Res 1992; 20 Suppl. I: 53A-61A
71. 71. Witsell DL, Garrett CG, Yarbrough WG, et al. Effect of lactobacillus acidophilus on antibiotic gastrointestinal morbidity: a prospective randomized trial. J Otolaryngol 1995; 24: 230-3
72. 72. D'Agostino RB, Kwan H. Measuring effectiveness: what to expect without a randomized control group. Med Care 1995; 33 (4 Suppl.): AS95-105
73. 73. O'Brien. Economic evaluation of pharmaceuticals: Frankenstein's monster or vampire trials? Med Care 1996; 34 (12 Suppl.): DS99-108